Dyskeratosis congenita (DC) is an inherited disorder characterized by skin
pigmentation, nail dystrophy and mucosal leucoplakia. In 1995 a Dyskeratosi
s Congenita Registry was established at the Hammersmith Hospital. In the 46
families recruited, 76/83 patients were male, suggesting that the major fo
rm of DC is X-linked. As well as a variety of noncutaneous abnormalities, t
he majority (93%) of patients had bone marrow (BM) failure and this was the
principal cause (71%) of early mortality In addition to BM hypoplasia, som
e patients also developed myelodysplasia and acute myeloid leukaemia. Pulmo
nary abnormalities were present in 19% of patients. In affected females the
phenotype was less severe. Some female carriers of X-linked DC had clinica
l features. Carriers of X-linked DC showed skewed X-chromosome inactivation
patterns (XCIPs), suggesting that cells expressing the normal DC allele ha
ve a growth/survival advantage over cells that express the mutant allele. L
inkage analysis in multiplex families confirmed that the DKC1 gene, respons
ible for the X-linked form of DC, is located within Xq28 and facilitated it
s positional cloning. The high incidence of BM failure in association with
a wide range of somatic abnormalities together with the ubiquitous expressi
on of DKC1 suggest that, as well as having a critical role in normal haemop
oiesis, this gene has a key role in normal cell biology.